Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients

Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients

Abstract Background Patients with malignancy are particularly vulnerable to infection with Severe Acute Respiratory Disease‐Coronavirus‐2 (SARS‐CoV‐2) given their immunodeficiency secondary to their underlying disease and cancer‐directed therapy. We report a case series of patients with cancer who r...

Full description

Bibliographic Details
Main Authors: Douglas Tremblay, Carina Seah, Thomas Schneider, Sheena Bhalla, Jonathan Feld, Leonard Naymagon, Bo Wang, Vaibhav Patel, Tomi Jun, Thomas Jandl, Farah Rahman, Sean T. H. Liu, Judith A. Aberg, Nicole Bouvier, The Mount Sinai Health System Convalescent Plasma Team
Format: Article
Language:English
Published: Wiley 2020-11-01
Series:Cancer Medicine
Subjects:
cancer
convalescent plasma
COVID‐19
malignancy
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/cam4.3457

Internet

https://doi.org/10.1002/cam4.3457

Similar Items